Latest Ratios: P/E Ratio 21.2x · EV/EBITDA 10.4x · ROE 3.5%. (2015–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.4B | $2.1B | $831M | $1.6B | $3.1B | $4.6B | $3.7B | $2.6B | $2.2B | $2.5B | — |
| Enterprise Value | $2.1B | $2.7B | $1.6B | $2.4B | $3.9B | $5.3B | $4.4B | $3.6B | $2.8B | $3.1B | — |
| P/E Ratio → | 21.17 | 70.14 | — | — | 74.54 | 33.56 | 102.93 | 81.07 | 93.90 | 58.01 | — |
| P/S Ratio | 0.68 | 1.05 | 0.46 | 0.77 | 1.89 | 2.22 | 2.19 | 1.54 | 1.45 | 1.83 | — |
| P/B Ratio | 1.62 | 2.40 | 1.02 | 1.98 | 3.45 | 4.98 | 4.14 | 3.41 | 3.00 | 3.82 | — |
| P/FCF | 20.55 | 28.47 | 21.78 | 28.13 | 550.76 | 28.23 | 23.71 | 41.55 | 1042.90 | — | — |
| P/OCF | 9.57 | 14.29 | 6.22 | 9.47 | 26.11 | 17.82 | 15.96 | 16.05 | 20.88 | 27.91 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.38 | 0.86 | 1.13 | 2.36 | 2.54 | 2.58 | 2.07 | 1.81 | 2.24 | — |
| EV / EBITDA | 10.38 | 17.04 | 17.73 | 46.91 | 25.44 | 19.08 | 24.75 | 22.16 | 23.89 | 23.87 | — |
| EV / EBIT | 33.57 | 46.85 | — | — | 73.64 | 30.19 | 50.81 | 55.86 | 66.13 | 51.61 | — |
| EV / FCF | — | 37.40 | 41.23 | 41.41 | 687.62 | 32.31 | 27.95 | 55.89 | 1305.65 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.2% | 54.2% | 58.1% | 52.9% | 59.4% | 56.5% | 54.0% | 53.2% | 53.6% | 53.7% | 54.5% |
| Operating Margin | 3.1% | 3.1% | -0.6% | -2.2% | 3.2% | 8.4% | 5.1% | 4.3% | 2.8% | 4.9% | 5.5% |
| Net Profit Margin | 1.5% | 1.5% | -1.6% | -3.1% | 2.6% | 6.2% | 2.1% | 1.9% | 1.5% | 3.3% | 1.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.5% | 3.5% | -3.5% | -7.6% | 4.6% | 14.0% | 4.3% | 4.3% | 3.4% | 8.6% | 3.7% |
| ROA | 1.5% | 1.5% | -1.4% | -3.0% | 1.8% | 5.5% | 1.7% | 1.8% | 1.5% | 2.9% | 1.0% |
| ROIC | 3.0% | 3.0% | -0.5% | -2.1% | 2.4% | 8.3% | 4.0% | 3.7% | 2.5% | 4.3% | 4.4% |
| ROCE | 3.9% | 3.9% | -0.6% | -2.5% | 2.7% | 8.8% | 4.6% | 4.6% | 3.0% | 5.0% | 5.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.80 | 0.80 | 1.00 | 1.11 | 1.11 | 1.05 | 1.15 | 1.23 | 0.78 | 0.86 | 1.86 |
| Debt / EBITDA | 4.31 | 4.31 | 9.20 | 17.95 | 6.57 | 3.52 | 5.85 | 5.93 | 4.95 | 4.41 | 6.30 |
| Net Debt / Equity | — | 0.75 | 0.91 | 0.93 | 0.86 | 0.72 | 0.74 | 1.18 | 0.75 | 0.86 | 1.84 |
| Net Debt / EBITDA | 4.07 | 4.07 | 8.36 | 15.04 | 5.06 | 2.41 | 3.76 | 5.68 | 4.81 | 4.37 | 6.26 |
| Debt / FCF | — | 8.93 | 19.45 | 13.27 | 136.86 | 4.08 | 4.24 | 14.34 | 262.75 | — | 97.95 |
| Interest Coverage | 3.46 | 3.46 | -0.59 | -3.15 | 114.21 | 6.83 | 1.80 | 1.92 | 1.12 | 1.00 | 1.70 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.55 | 0.55 | 0.53 | 1.00 | 1.38 | 1.50 | 1.72 | 0.86 | 1.01 | 0.77 | 0.74 |
| Quick Ratio | 0.33 | 0.33 | 0.33 | 0.70 | 1.02 | 1.14 | 1.39 | 0.39 | 0.47 | 0.34 | 0.30 |
| Cash Ratio | 0.09 | 0.09 | 0.16 | 0.38 | 0.67 | 0.89 | 1.14 | 0.14 | 0.08 | 0.02 | 0.02 |
| Asset Turnover | — | 1.00 | 0.91 | 0.98 | 0.72 | 0.91 | 0.73 | 0.85 | 0.93 | 0.87 | 0.78 |
| Inventory Turnover | 10.20 | 10.20 | 8.14 | 8.35 | 5.42 | 7.32 | 7.07 | 6.32 | 6.15 | 6.99 | 6.26 |
| Days Sales Outstanding | — | 10.53 | 10.00 | 14.91 | 17.73 | 9.78 | 12.37 | 9.41 | 12.05 | 11.46 | 10.49 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | 6.8% | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | 373.2% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.7% | 1.4% | — | — | 1.3% | 3.0% | 1.0% | 1.2% | 1.1% | 1.7% | — |
| FCF Yield | 4.9% | 3.5% | 4.6% | 3.6% | 0.2% | 3.5% | 4.2% | 2.4% | 0.1% | — | — |
| Buyback Yield | 0.2% | 0.2% | 0.4% | 1.7% | 2.7% | 1.6% | 0.0% | 1.0% | 0.1% | 0.0% | — |
| Total Shareholder Yield | 0.2% | 0.2% | 0.4% | 1.7% | 2.7% | 1.6% | 0.0% | 1.0% | 0.1% | 6.8% | — |
| Shares Outstanding | — | $81M | $79M | $78M | $80M | $96M | $83M | $82M | $79M | $62M | $72M |
Includes 30+ ratios · 11 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EYE stock.
National Vision Holdings, Inc.'s current P/E ratio is 21.2x. The historical average is 73.5x.
National Vision Holdings, Inc.'s current EV/EBITDA is 10.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 24.5x.
National Vision Holdings, Inc.'s return on equity (ROE) is 3.5%. The historical average is 3.3%.
Based on historical data, National Vision Holdings, Inc. is trading at a P/E of 21.2x. Compare with industry peers and growth rates for a complete picture.
National Vision Holdings, Inc. has 54.2% gross margin and 3.1% operating margin.
National Vision Holdings, Inc.'s Debt/EBITDA ratio is 4.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Thin margins and optometrist shortage
Metrics are mathematically derived from official filings.
Premium Multiple Against Thin Margins
Based on EYE's reported figures, the trailing P/E of 22.70 and forward P/E of 26.76 imply the market is pricing in margin expansion well beyond the current 1.5% net margin, which sits well below own historical norms.
The forward P/E exceeding the trailing multiple suggests consensus expects earnings to be lower over the next twelve months, which may reflect transition costs from the Walmart wind-down rather than a durable growth path. Relative to Envista at 6.20x and Henry Schein at 22.71x, EYE trades in the upper part of the peer range despite a lower ROE of 3.5%, so investors appear to be paying for recovery optionality rather than current earning power. The EV/EBITDA of 10.89x looks more defensible than the P/E, but it still requires confidence that operating margins recover from 6.1% toward levels that justify the premium.
Gross Gains Trapped Above the Operating Line
As reported in quarterly income statements, EYE's gross margin rose from 53.5% in 2025Q4 to 58.9% in 2026Q3, yet operating margin reached only 6.1%, indicating most incremental gross profit is consumed by SG&A and clinical labor costs.
The widening gap between gross and operating margin suggests the cost structure is absorbing gains faster than they accumulate, which is consistent with a high fixed-cost base of optometrists and store occupancy. The operating margin peaked at 8.3% in 2026Q1 and has since declined, which may indicate the recent improvement is cyclical rather than structural. Investors should monitor whether SG&A growth stays below revenue growth, since the 3.8% net margin leaves little room for further cost inflation.
Returns Recovering From a Loss-Making Base
Based on EYE's reported ratios, ROIC improved from negative levels in 2024 to 1.5% in 2026Q3, yet this remains well below the 5-7% range of peers such as Driven Brands and Henry Schein, suggesting the capital base is still earning sub-par returns.
The trajectory from -0.4% ROIC in 2024Q3 to 2.2% in 2026Q1 suggests returns are compounding off a low base, but the improvement has been uneven and the latest quarter reflects a pullback. ROE of 2.1% combined with a Debt/Equity ratio of 0.76 indicates that leverage is not amplifying equity returns meaningfully, which may reflect the drag from goodwill-heavy assets. Whether returns can rise toward peer levels depends on sustaining operating margins well above current readings.
Debt Burden Easing but Still Material
According to reported figures, EYE's Debt/Equity fell from 1.00 in 2024Q4 to 0.76 in 2026Q3 and interest coverage recovered to 10.4x, yet the debt-to-EBITDA ratio of 12.8x indicates leverage relative to operating cash earnings remains elevated.
The improvement in interest coverage from near 1.6x in late 2025 suggests debt service has become more comfortable, though the 12.8x debt-to-EBITDA multiple implies the company would require a long period of sustained earnings to deleverage meaningfully. The gap between coverage and leverage metrics may reflect that interest costs are modest relative to a debt load that is large against thin EBITDA. Refinancing risk and covenant headroom are not disclosed in the supplied data and warrant further investigation.
Current Liabilities Exceed Liquid Assets
Based on EYE's reported balance sheet, the current ratio of 0.63 and quick ratio of 0.33 indicate current liabilities materially exceed current assets, leaving a thin near-term cushion against operating shocks.
The quick ratio sitting at roughly half the current ratio suggests inventory is a large share of current assets, so liquidity depends on turning inventory into cash rather than on cash reserves alone. With only $60.0M of cash on hand, a severe demand or payer reimbursement shock could pressure the company's ability to meet short-term obligations without drawing on credit facilities. Whether this reflects structural working capital needs or temporary timing effects is not clear from the supplied data and should be monitored.
Misapplied P/E in a Leveraged Retailer
The trailing P/E of 22.70 is most commonly misapplied to EYE because reported net income of 1.5% margin is distorted by non-recurring items and timing effects, obscuring the underlying earning power that EV/EBITDA better captures.
P/E treats a thin, volatile net margin as a stable earnings base, which may overstate or understate value depending on whether quarterly charges are truly non-recurring. EV/EBITDA is less distorted by the heavy debt load and goodwill amortization, though it ignores the substantial lease and labor obligations that define the clinical model. A more reliable framing would combine EV/EBITDA with a normalized operating margin trend and free cash flow yield rather than relying on the P/E headline.